A teaching videotape for the assessment of essential tremor

Autor: Kristin J. Wendt, Anthony E. Lang, Petra Kaufmann, Maria Sangiorgio, Cynthia L. Comella, Linda D. Lewis, Carol Moskowitz, Elan D. Louis, Blair Ford, Christopher C. Goetz, Livia F. Barnes, Samer Tabbal

Publikováno v: Movement Disorders. 16:89-93

Teaching videotapes, developed to aid in the evaluation of several movement disorders, have not been used in essential tremor research. As part of the Washington Heights-Inwood Genetic Study of Essential Tremor (WHIGET), we developed a reliable and v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3f487988147a60a5f8af809b37052643
https://doi.org/10.1002/1531-8257(200101)16:1<89::aid-mds1001>3.0.co

Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom.

Autor: Otero-Losada M; Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Abierta Interamericana-Centro de Altos Estudios en Ciencias Humanas y de La Salud, UAI-CAECIHS CONICET, Buenos Aires, Argentina., Petrovsky N; Flinders University, Bedford Park, Australia.; Vaxine, Bedford Park, Australia., Alami A; Faculty of Medicine University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, Ottawa, Ontario, Canada.; Risk Sciences International, Ottawa, Ontario, Canada., Crispo JA; School of Mathematics and Statistics, Carleton University, Ottawa, Ontario, Canada.; Human Sciences Division, Northern Ontario School of Medicine, Sudbury, Ontario, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Ontario, Canada., Mattison D; Faculty of Medicine University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, Ottawa, Ontario, Canada.; Risk Sciences International, Ottawa, Ontario, Canada.; Arnold School of Public Health, University of South Carolina, Columbia, Ontario, USA.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., Capani F; Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Abierta Interamericana-Centro de Altos Estudios en Ciencias Humanas y de La Salud, UAI-CAECIHS CONICET, Buenos Aires, Argentina.; Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Santiago de Chile, Chile., Goetz C; Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA., Krewski D; Faculty of Medicine University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, Ottawa, Ontario, Canada.; Risk Sciences International, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., Perez-Lloret S; Observatorio de Salud Pública, Pontificia Universidad Católica Argentina, Buenos Aires, Argentina.; Department of Physiology, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.

Publikováno v: Expert opinion on drug safety [Expert Opin Drug Saf] 2023 Apr; Vol. 22 (4), pp. 343-349. Date of Electronic Publication: 2022 Sep 07.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.

Autor: Schwarzschild MA; Mass General Institute for Neurodegenerative Disease, Boston, Massachusetts.; Massachusetts General Hospital, Boston., Ascherio A; Harvard School of Public Health, Boston, Massachusetts., Casaceli C; University of Rochester, Rochester, New York., Curhan GC; Brigham and Women's Hospital, Boston, Massachusetts., Fitzgerald R; Parkinson's Foundation Research Advocates, Parkinson's Foundation, New York, New York., Kamp C; University of Rochester, Rochester, New York., Lungu C; Division of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland., Macklin EA; Massachusetts General Hospital, Boston.; Harvard Medical School, Boston, Massachusetts., Marek K; Institute for Neurodegenerative Disorders, New Haven, Connecticut., Mozaffarian D; Tufts School of Medicine and Division of Cardiology, Tufts Medical Center, Boston, Massachusetts.; Friedman School of Nutrition Science and Policy, Boston, Massachusetts., Oakes D; University of Rochester, Rochester, New York., Rudolph A; University of Rochester, Rochester, New York., Shoulson I; Department of Neurology, University of Rochester Medical Center, Rochester, New York., Videnovic A; Massachusetts General Hospital, Boston., Scott B; Duke University, Durham, North Carolina., Gauger L; Duke Medical Center, Durham, North Carolina., Aldred J; Inland Northwest Research, Spokane, Washington.; Selkirk Neurology, Spokane, Washington., Bixby M; Inland Northwest Research, Spokane, Washington., Ciccarello J; Inland Northwest Research, Spokane, Washington., Gunzler SA; University Hospitals Cleveland Medical Center, Cleveland, Ohio., Henchcliffe C; University of California, Irvine.; Weill Cornell Medical College, New York, New York., Brodsky M; Oregon Health & Science University, Portland., Keith K; Oregon Health & Science University, Portland., Hauser RA; University of South Florida, Tampa., Goetz C; Rush University Medical Center, Chicago, Illinois., LeDoux MS; Veracity Neuroscience LLC, Memphis, Tennessee., Hinson V; Medical University of South Carolina, Charleston., Kumar R; Rocky Mountain Movement Disorders Center, Englewood, Colorado., Espay AJ; University of Cincinnati, Cincinnati, Ohio., Jimenez-Shahed J; Icahn School of Medicine at Mount Sinai, New York, New York., Hunter C; Baylor College of Medicine, Houston, Texas., Christine C; University of California, San Francisco., Daley A; University of California, San Francisco., Leehey M; University of Colorado, Denver., de Marcaida JA; Ayer Neuroscience Institute, Hartford HealthCare, Hartford, Connecticut., Friedman JH; Butler Hospital, Providence, Rhode Island., Hung A; Massachusetts General Hospital, Boston., Bwala G; Massachusetts General Hospital, Boston., Litvan I; University of California, San Diego., Simon DK; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Simuni T; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Poon C; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Schiess MC; The University of Texas Health Science Center, Houston McGovern Medical School, Houston., Chou K; University of Michigan, Ann Arbor., Park A; The Ohio State University Wexner Medical Center, Columbus., Bhatti D; University of Nebraska Medical Center, Omaha., Peterson C; University of Nebraska Medical Center, Omaha., Criswell SR; Washington University School of Medicine in St Louis, St Louis, Missouri., Rosenthal L; Johns Hopkins School of Medicine, Baltimore, Maryland., Durphy J; Albany Medical College, Albany, New York., Shill HA; Banner Sun Health Research Institute, Sun City, Arizona.; University of Arizona School of Medicine-Phoenix., Mehta SH; Mayo Clinic Arizona, Scottsdale., Ahmed A; Cleveland Clinic, Cleveland, Ohio., Deik AF; University of Pennsylvania, Philadelphia., Fang JY; Vanderbilt University Medical Center, Nashville, Tennessee., Stover N; The University of Alabama at Birmingham., Zhang L; UC Davis, Davis, California., Dewey RB Jr; University of Texas Southwestern Medical Center, Dallas., Gerald A; University of Texas Southwestern Medical Center, Dallas., Boyd JT; University of Vermont, Burlington., Houston E; University of Vermont Medical Center, Burlington., Suski V; University of Pittsburgh, Pittsburgh, Pennsylvania., Mosovsky S; University of Pittsburgh, Pittsburgh, Pennsylvania., Cloud L; VCU Parkinson's & Movement Disorders Center, Richmond, Virginia., Shah BB; University of Virginia, Charlottesville., Saint-Hilaire M; Boston University School of Medicine, Boston, Massachusetts., James R; Boston Medical Center, Boston, Massachusetts., Zauber SE; Indiana University, Bloomington., Reich S; University of Maryland School of Medicine, Baltimore., Shprecher D; Banner Sun Health Research Institute, Sun City, Arizona.; University of Arizona School of Medicine-Phoenix., Pahwa R; University of Kansas Medical Center, Kansas City., Langhammer A; University of Kansas Medical Center, Kansas City., LaFaver K; Northwestern University Feinberg School of Medicine, Chicago, Illinois., LeWitt PA; Henry Ford Hospital-West Bloomfield, West Bloomfield Township, Michigan., Kaminski P; Henry Ford Hospital-West Bloomfield, West Bloomfield Township, Michigan., Goudreau J; Michigan State University, East Lansing., Russell D; Michigan State University, East Lansing., Houghton DJ; Ochsner Medical Center, Jefferson, Louisiana., Laroche A; Ochsner Health System, Jefferson, Louisiana., Thomas K; Sentara Neurology Specialists, Norfolk, Virginia., McGraw M; Center for Movement Disorders and Neurodegenerative Disease, Northwestern Medicine/Central DuPage Hospital, Winfield, Illinois., Mari Z; Cleveland Clinic-Las Vegas, Las Vegas, Nevada., Serrano C; University of Puerto Rico, San Juan., Blindauer K; Medical College of Wisconsin, Milwaukee., Rabin M; Atlantic Neuroscience Institute, Summit, New Jersey., Kurlan R; Atlantic Neuroscience Institute, Summit, New Jersey., Morgan JC; Augusta University, Augusta, Georgia., Soileau M; Texas Movement Disorder Specialists, Georgetown.; Scott & White Healthcare/Texas A&M University, Temple., Ainslie M; Baylor Scott & White Health, Temple, Texas., Bodis-Wollner I; State University of New York Downstate Medical Center, Brooklyn., Schneider RB; University of Rochester, Rochester, New York., Waters C; Columbia University, New York, New York., Ratel AS; Columbia University, New York, New York., Beck CA; University of Rochester Medical Center, Rochester, New York., Bolger P; University of Rochester, Rochester, New York., Callahan KF; Massachusetts General Hospital, Boston., Crotty GF; Massachusetts General Hospital, Boston., Klements D; Massachusetts General Hospital, Boston., Kostrzebski M; University of Rochester, Rochester, New York., McMahon GM; Brigham and Women's Hospital, Boston, Massachusetts., Pothier L; Massachusetts General Hospital, Boston., Waikar SS; Boston University School of Medicine, Boston, Massachusetts.; Boston Medical Center, Boston, Massachusetts., Lang A; University of Toronto, Toronto, Ontario, Canada.; Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada., Mestre T; University of Ottawa, Ottawa, Ontario, Canada.

Publikováno v: JAMA [JAMA] 2021 Sep 14; Vol. 326 (10), pp. 926-939.

Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.

Autor: Pal GD; Department of Neurological Sciences, Rush University, Chicago, Illinois, USA., Ouyang B; Department of Neurological Sciences, Rush University, Chicago, Illinois, USA., Serrano G; Banner Sun Health Research Institute, Sun City, Arizona, USA., Shill HA; Banner Sun Health Research Institute, Sun City, Arizona, USA., Goetz C; Department of Neurological Sciences, Rush University, Chicago, Illinois, USA., Stebbins G; Department of Neurological Sciences, Rush University, Chicago, Illinois, USA., Metman LV; Department of Neurological Sciences, Rush University, Chicago, Illinois, USA., Driver-Dunckley E; Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA., Mehta SH; Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA., Caviness JN; Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA., Sabbagh MN; Banner Sun Health Research Institute, Sun City, Arizona, USA., Adler CH; Banner Sun Health Research Institute, Sun City, Arizona, USA.; Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA., Beach TG; Banner Sun Health Research Institute, Sun City, Arizona, USA.; Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.

Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2017 Feb; Vol. 32 (2), pp. 274-277. Date of Electronic Publication: 2016 Dec 02.

Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.

Autor: Schwid SR; Department of Neurology, University of Rochester, Rochester, New York, USA., Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I, Shoulson I, Hyson C, Oakes D, Flagg E, Rudolph A, Kieburtz K, Lang A, Fahn S, Gauger L, Goetz C

Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2010 Sep 15; Vol. 25 (12), pp. 1801-8.